HLA-A antibody (PE-Cy5)

Catalog No. ABIN2659031

The PE-Cy5-conjugated Mouse Monoclonal anti-HLA-A antibody (Clone W6-32) (ABIN2659031) specifically detects HLA-A in FACS and ICFC. The antibody is reactive with Human samples.

Quick Overview for HLA-A antibody (PE-Cy5) (ABIN2659031)

Target: HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This HLA-A antibody is conjugated to PE-Cy5

Application: Flow Cytometry (FACS), Intracellular Flow Cytometry (ICFC)

Clone: W6-32

Product Details anti-HLA-A Antibody (PE-Cy5)

Cross-Reactivity: Chimpanzee, Baboon, Cynomolgus, Rhesus Monkey, Cow (Bovine), Cat (Feline)

Purification: The antibody was purified by affinity chromatography, and conjugated with PE/Cy5 under optimal conditions. The solution is free of unconjugated PE/Cy5 and unconjugated antibody.

Isotype: IgG2a kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Protect from prolonged exposure to light. Do not freeze.

Storage: 4 °C

Storage Comment: The antibody solution should be stored undiluted between 2°C and 8°C.

Target Details for HLA-A

Target: HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))

Alternative Name: HLA-A

Background: MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8+ T cells. They play an important role in cell-mediated immune responses and tumor surveillance.

Pathways: TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response